The broad objective of this research proposal is to study interorgan glutamine metabolism in the tumor-bearing rat and investigate the causes and consequences of the glutamine depletion in advanced malignant disease. We hypothesize that the presence of advanced malignant disease alters interorgan glutamine metabolism, which is an integral part of nitrogen metabolism in critical illness and may be a significant component of cancer cachexia. Glutamine, the most abundant amino acid in blood and tissues, is the principal carrier of nitrogen from skeletal muscle to visceral organs. It is avidly consumed by gut-mucosal cells and tumor cells, which demonstrate a striking similarity between patterns of substrate utilization. With progressive malignant disease there may be excessive glutamine utilization by the tumor which contributes to a depletion of glutamine stores. A fall in circulating glutamine may alter intestinal glutamine metabolism and result in architectural changes in the gut mucosa. The research focuses on interorgan glutamine metabolism in the tumor-bearing rat. First, we will study the relationship between tumor size, food intake and circulating glutamine concentrations. Next, we will measure the flux of glutamine across the gut, liver, and hindquarter. By comparing glutamine exchange across the tumor- bearing and nontumor-bearing extremities, we will determine glutamine uptake by the growing tumor. We will then examine the consequences of glutamine depletion secondary to the tumor. We will study intestinal histology and cell proliferation and measure glutamine levels in muscle and liver. The activities of the glutamine synthetase and glutaminase enzymes will be measured. We will also study the regulation of plasma membrane glutamine transport in enterocytes and hepatocytes. Finally, the impact of glutamine feeding on interorgan glutamine metabolism in the tumor- bearing rat will be studied. This work is relevant to major health care problem since cancer is a principal cause of death and disability and is characterized by abnormal glutamine metabolism. Moreover, current parenteral amino acid solutions used to feed cancer patients do not contain glutamine. An improved understanding of glutamine metabolism in the host with advanced malignant disease not only provides further knowledge of alterations in intermediary metabolism and metabolic regulation in cancer, but also allows for the design of more specific and effective nutritional formulations which may require glutamine supplementation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA045327-05
Application #
3458358
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1988-07-01
Project End
1993-03-31
Budget Start
1992-07-01
Budget End
1993-03-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Oishi, A J; Inoue, Y; Souba, W W et al. (1996) Alterations in carrier-mediated glutamine transport after a model of canine jejunal autotransplantation. Dig Dis Sci 41:1915-24
Dudrick, P S; Souba, W W (1994) Cytokines, sepsis, and the surgeon: a perspective. Surg Annu 26:1-26
Espat, N J; Copeland, E M; Souba, W W (1994) Accelerated hepatic arginine transport in the tumor-bearing rat. Ann Surg Oncol 1:147-56
Sarantos, P; Abouhamze, A; Abcouwer, S et al. (1994) Cytokines decrease glutaminase expression in human fibroblasts. Surgery 116:276-83;discussion 283-4
Inoue, Y; Bode, B P; Souba, W W (1994) Antibody to tumor necrosis factor attenuates endotoxin-stimulated amino acid transport in rat liver. Surgery 116:356-65;discussion 365-6
Inoue, Y; Copeland, E M; Souba, W W (1994) Growth hormone enhances amino acid uptake by the human small intestine. Ann Surg 219:715-22;discussion 722-4
Watkins, K T; Copeland, E M; Souba, W W (1994) Induction of hepatic system y(+)-mediated L-arginine transport by prostaglandin E2. Am J Surg 167:128-33;discussion 133-4
Sarantos, P; Abouhamze, A; Chakrabarti, R et al. (1994) Glucocorticoids regulate intestinal glutamine synthetase gene expression in endotoxemia. Arch Surg 129:59-65
Watkins, K T; Dudrick, P S; Copeland, E M et al. (1994) Interleukin-6 and dexamethasone work coordinately to augment hepatic amino acid transport. J Trauma 36:523-8
Sarantos, P; Abouhamze, Z; Copeland, E M et al. (1994) Decrease of glutaminase expression by interferon-gamma in human intestinal epithelial cells. Ann Surg Oncol 1:428-35

Showing the most recent 10 out of 68 publications